PT Kimia Farma (Persero) Tbk reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was IDR 4,425,143.86 million compared to IDR 5,558,524.13 million a year ago. Net loss was IDR 205,122.71 million compared to net income of IDR 57,600.34 million a year ago.

Basic loss per share from continuing operations was IDR 36.93 compared to basic earnings per share from continuing operations of IDR 10.37 a year ago.